1. Zong H, Parada LF, Baker SJ (2015) Cell of Origin for Malignant Gliomas and Its Implication in Therapeutic Development. Cold Spring Harb Perspect Biol 7:a020610. https://doi.org/10.1101/cshperspect.a020610
2. Iacob G, Dinca EB (2009) Current data and strategy in glioblastoma multiforme. J Med Life 2:386–393
3. Young RM, Jamshidi A, Davis G, Sherman JH (2015) Current trends in the surgical management and treatment of adult glioblastoma. Ann Transl Med 3:121. https://doi.org/10.3978/j.issn.2305-5839.2015.05.10
4. Goel A, Shah A, Redhu R, Nadkarni T (2010) Supratentorial glioblastoma multiforme with spinal metastases. J Craniovertebral Junction Spine 1:126. https://doi.org/10.4103/0974-8237.77678
5. Dardis C, Milton K, Ashby L, Shapiro W (2014) Leptomeningeal Metastases in High-Grade Adult Glioma: Development, Diagnosis, Management, and Outcomes in a Series of 34 Patients. Front Neurol 5:. https://doi.org/10.3389/fneur.2014.00220
6. Andersen BM, Miranda C, Hatzoglou V, et al (2019) Leptomeningeal metastases in glioma: The Memorial Sloan Kettering Cancer Center experience. Neurology 92:e2483–e2491. https://doi.org/10.1212/WNL.0000000000007529
7. Mandel JJ, Yust-Katz S, Cachia D, et al (2014) Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution. J Neurooncol 120:597–605. https://doi.org/10.1007/s11060-014-1592-1
8. Vollmer K, Pantazis G, Añon J, et al (2019) Spinal Metastases of Supratentorial Glioblastoma with Primitive Neuronal Component. World Neurosurg X 2:100019. https://doi.org/10.1016/j.wnsx.2019.100019
9. Amitendu S, Mak SKD, Ling JM, Ng WH (2012) A single institution experience of the incidence of extracranial metastasis in glioma. J Clin Neurosci 19:1511–1515. https://doi.org/10.1016/j.jocn.2011.08.040
10. Sibanda Z, Farahani N, Ogbonnaya E, Albanese E (2020) Glioblastoma Multiforme: A Rare Case of Spinal Drop Metastasis. World Neurosurg 144:24–27. https://doi.org/10.1016/j.wneu.2020.08.086
11. Schwartz C, Romagna A, Machegger L, et al (2018) Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype. World Neurosurg 120:442–447. https://doi.org/10.1016/j.wneu.2018.09.082
12. Masters LT, Miller DC, Nelson PK (2000) Cerebral vasculopathy secondary to leptomeningeal gliomatosis: angiography. Neuroradiology 42:139–141. https://doi.org/10.1007/s002340050033
13. Serrano L, Archavlis E, Januschek E, et al (2017) Spinal Intradural Intramedullary Dissemination in the Absence of Intracranial Relapse of a Previously Radically Treated Temporal Lobe Glioblastoma Multiforme. Case Rep Oncol 10:281–289. https://doi.org/10.1159/000464279
14. Witoonpanich P, Bamrungrak K, Jinawath A, et al (2011) Glioblastoma multiforme at the corpus callosum with spinal leptomeningeal metastasis. Clin Neurol Neurosurg 113:407–410. https://doi.org/10.1016/j.clineuro.2010.12.001
15. Birzu C, Tran S, Bielle F, et al (2020) Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges. The Oncologist 25:. https://doi.org/10.1634/theoncologist.2020-0258
16. Mistry AM, Kelly PD, Gallant J-N, et al (2019) Comparative Analysis of Subventricular Zone Glioblastoma Contact and Ventricular Entry During Resection in Predicting Dissemination, Hydrocephalus, and Survival. Neurosurgery 85:E924–E932. https://doi.org/10.1093/neuros/nyz144
17. You HJ, Park H-Y, Kim J, et al (2016) Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination: Medicine (Baltimore) 95:e4109. https://doi.org/10.1097/MD.0000000000004109
18. Intriago B, Danús M, Añaños M, et al (2011) 18F-FDG PET detection of spinal leptomeningeal metastases from cerebral glioblastoma multiforme. Eur J Nucl Med Mol Imaging 38:1392–1392. https://doi.org/10.1007/s00259-011-1750-z
19. Alnahhas I, Guillermo Prieto Eibl P, Gonzalez J, et al (2019) Leptomeningeal spread of glioma in the molecular era. J Clin Oncol 37:e13537–e13537. https://doi.org/10.1200/JCO.2019.37.15_suppl.e13537
20. Korshunov A, Sycheva R, Golanov A, Pronin I (2007) Gains at the 1p36 Chromosomal Region Are Associated With Symptomatic Leptomeningeal Dissemination of Supratentorial Glioblastomas. Am J Clin Pathol 127:585–590. https://doi.org/10.1309/DE4LNX3YMACCC1ER
21. Nunn A, Polyzoidis S, Piechowski-Jozwiak B, et al (2017) Primary glioblastoma multiforme of the conus medullaris with leptomeningeal metastasis. J Neurol Sci 381:315–317. https://doi.org/10.1016/j.jns.2017.09.004
22. Broniscer A, Chintagumpala M, Fouladi M, et al (2006) Temozolomide after Radiotherapy for Newly Diagnosed High-grade Glioma and Unfavorable Low-grade Glioma in Children. J Neurooncol 76:313–319. https://doi.org/10.1007/s11060-005-7409-5
23. Routman DM, Yan E, Vora S, et al (2018) Preoperative Stereotactic Radiosurgery for Brain Metastases. Front Neurol 9:959. https://doi.org/10.3389/fneur.2018.00959
24. Buszek SM, Chung C (2019) Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-randomized Trials. Front Oncol 9:. https://doi.org/10.3389/fonc.2019.01224
25. Kwon J-E, Hwang K, Go K-O, et al (2020) Clinical Characteristics of High-Grade Glioma with Primary Leptomeningeal Seeding at Initial Diagnosis in a Single Center Study. Brain Tumor Res Treat 8:77. https://doi.org/10.14791/btrt.2020.8.e18
26. Burger MC, Zeiner PS, Jahnke K, et al (2016) Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors. PLOS ONE 11:e0155315. https://doi.org/10.1371/journal.pone.0155315
27. Toh CH, Liau C-T, Wei K-C, Castillo M (2019) Baseline multicentric tumors, distant recurrences and leptomeningeal dissemination predict poor survival in patients with recurrent glioblastomas receiving bevacizumab. J Neurooncol 142:149–159. https://doi.org/10.1007/s11060-018-03075-x
28. Okita Y, Nonaka M, Umehara T, et al (2015) Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report. Oncol Lett 9:1885–1888. https://doi.org/10.3892/ol.2015.2940
29. Engelhard HH, Corsten LA (2005) Leptomeningeal Metastasis of Primary Central Nervous System (CNS) Neoplasms. In: Abrey LE, Chamberlain MC, Engelhard HH (eds) Leptomeningeal Metastases. Springer-Verlag, New York, pp 71–85
30. Herrlinger U, Förschler H, Küker W, et al (2004) Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci 223:167–178. https://doi.org/10.1016/j.jns.2004.05.008
31. Noh J-H, Lee MH, Kim WS, et al (2015) Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome. Acta Neurochir (Wien) 157:569–576. https://doi.org/10.1007/s00701-015-2344-5
32. Witham TF, Fukui MB, Meltzer CC, et al (1999) Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis. Cancer 86:1347–1353. https://doi.org/10.1002/(sici)1097-0142(19991001)86:7<1347::aid-cncr34>3.0.co;2-m
33. Engelhard HH, Willis AJ, Hussain SI, et al (2020) Etoposide-Bound Magnetic Nanoparticles Designed for Remote Targeting of Cancer Cells Disseminated Within Cerebrospinal Fluid Pathways. Front Neurol 11:596632. https://doi.org/10.3389/fneur.2020.596632
34. Brown CE, Alizadeh D, Starr R, et al (2016) Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. N Engl J Med 375:2561–2569. https://doi.org/10.1056/nejmoa1610497
35. Hong B, Polemikos M, Heissler HE, et al (2018) Challenges in cerebrospinal fluid shunting in patients with glioblastoma. Fluids Barriers CNS 15:16. https://doi.org/10.1186/s12987-018-0101-x
36. Fischer CM, Neidert MC, Péus D, et al (2014) Hydrocephalus after resection and adjuvant radiochemotherapy in patients with glioblastoma. Clin Neurol Neurosurg 120:27–31. https://doi.org/10.1016/j.clineuro.2014.02.012
37. Inamasu J, Nakamura Y, Saito R, et al (2003) Postoperative communicating hydrocephalus in patients with supratentorial malignant glioma. Clin Neurol Neurosurg 106:9–15. https://doi.org/10.1016/S0303-8467(03)00060-X
38. Onuma K, Ishikawa E, Matsuda M, et al (2013) Clinical Characteristics and Neuroimaging Findings in 12 Cases of Recurrent Glioblastoma With Communicating Hydrocephalus. Neurol Med Chir (Tokyo) 53:474–481. https://doi.org/10.2176/nmc.53.474
39. Kim HS, Park JB, Gwak H-S, et al (2019) Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis. World J Surg Oncol 17:. https://doi.org/10.1186/s12957-019-1595-7
40. Woo PYM, Zhuang JTF, Ho JMK, et al (2018) Intraventricular urokinase to treat a blocked ventriculoperitoneal shunt in a glioblastoma patient with leptomeningeal spread. Acta Neurochir (Wien) 160:1073–1077. https://doi.org/10.1007/s00701-018-3509-9
41. Zada G, Chen TC (2010) A Novel Method for Administering Intrathecal Chemotherapy in Patients With Leptomeningeal Metastases and Shunted Hydrocephalus: Case Report. Oper Neurosurg 67:ons-ons. https://doi.org/10.1227/01.neu.0000383138.78632.ba
42. Burger M, Wagner M, Franz K, et al (2018) Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases. J Clin Med 7:216. https://doi.org/10.3390/jcm7080216